UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934
Date of Report (Date of earliest event reported): May 4, 2006 (May 3, 2006)
REGENERON PHARMACEUTICALS, INC.
(Exact name of registrant as specified in its charter)
| |
|
|
|
|
New
York |
|
000-19034
|
|
133444607
|
| (State or other jurisdiction of incorporation)
|
|
(Commission File Number)
|
|
(I.R.S. Employer Identification Number) |
777 Old Saw Mill River Road, Tarrytown, New York 10591-6707
(Address of principal executive offices)
(Zip Code)
(914) 347-7000
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy
the filing obligation of registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c))
TABLE OF CONTENTS
|
|
|
| Item 2.02 |
|
Results of Operations and Financial Condition |
On
May 3, 2006, Regeneron Pharmaceuticals, Inc. issued a press
release announcing its
financial and operating results for the quarter and three months
ended March 31, 2006. The press release is being furnished to
the Securities and Exchange Commission pursuant to Item 2.02 of
Form 8-K and is attached hereto as Exhibit 99(a).
|
|
|
| Item 9.01 |
|
Financial Statements and Exhibits |
(c) Exhibits
99(a) Press Release of Regeneron Pharmaceuticals, Inc. dated May 3, 2006.
Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| |
|
|
|
|
|
|
| |
|
REGENERON PHARMACEUTICALS, INC. |
|
|
|
|
|
|
|
|
|
Dated: May 4, 2006
|
|
By:
|
|
/s/ Stuart Kolinski
Stuart Kolinski
|
|
|
|
|
|
|
Vice President and General Counsel |
|
|
2